{
    "2019-09-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-30",
                "original_text": "Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Pay",
                        "SEC Charges",
                        "EpiPen"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-12-31",
                "original_text": "Pfizer, Walgreens, UnitedHealth, Dow, 3M Are 5 Worst Dow Jones Stocks This Year",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Walgreens",
                        "UnitedHealth",
                        "Dow",
                        "3M",
                        "Worst Dow Jones Stocks"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "retail",
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-30",
                "original_text": "Pfizer's JAK1 Inhibitor Meets All Goals in 2nd Phase III Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "JAK1 Inhibitor",
                        "Phase III Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-09-30",
                "original_text": "Company News For Sep 30, 2019",
                "features": {
                    "keywords": [
                        "Company News",
                        "Sep 30"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-09-30",
                "original_text": "California investor buys 67,000-square-foot facility in Durham",
                "features": {
                    "keywords": [
                        "California investor",
                        "buys",
                        "facility",
                        "Durham"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "real estate"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-09-30",
                "original_text": "Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Interim Analysis",
                        "Phase 3 BEACON CRC Trial",
                        "BRAFTOVI",
                        "MEKTOVI",
                        "Cetuximab",
                        "BRAFV600E-Mutant",
                        "Metastatic Colorectal Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}